Prostatic urethral lift improves the outcomes of patients with benign prostatic hyperplasia

This study investigated the effectiveness of prostatic urethral lift (PUL) in the treatment of benign prostatic hyperplasia (BPH). Researchers suggested that this treatment is a good and safe option to treat BPH.

BHP consists of the enlargement of the prostate gland. This may compress the urethra (urinary tube) causing urinary symptoms. Around 42% of men aged 51 to 60 have BHP. Treatment options for BPH include medication and surgery. However, both methods are associated with poor response and side effects such as sexual dysfunction.  

PUL is a less invasive procedure associated with improved outcomes and fewer side effects. It involves using stitches to hold the prostate away from the urethra. This allows urine to flow more freely. However, the long-term effectiveness of this method is still not clear.

This study reviewed 5 other studies including information about 322 patients with BPH. Patients underwent PUL and were followed for at least 24 months.

At 24 months, patients had significant improvements in urinary symptoms. Quality of life was also significantly improved after PUL.

Side effects included mild pain during urination and bloody urine. These resolved over 2-3 weeks.

This study concluded that prostatic urethral lift is a good and safe option for the treatment of BHP, without increased safety issues.

This study analyzed the results of 5 small studies with different protocols. Further large, controlled studies are needed for stronger evidence.